Rapa v. Novartis Pharmaceuticals Corp.

53 F. Supp. 3d 1150, 2014 U.S. Dist. LEXIS 146587, 2014 WL 5161311
CourtDistrict Court, E.D. Missouri
DecidedOctober 15, 2014
DocketCase No. 4:08CV01671 AGF
StatusPublished

This text of 53 F. Supp. 3d 1150 (Rapa v. Novartis Pharmaceuticals Corp.) is published on Counsel Stack Legal Research, covering District Court, E.D. Missouri primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Rapa v. Novartis Pharmaceuticals Corp., 53 F. Supp. 3d 1150, 2014 U.S. Dist. LEXIS 146587, 2014 WL 5161311 (E.D. Mo. 2014).

Opinion

MEMORANDUM AND ORDER

AUDREY G. FLEISSIG, District Judge.

This diversity matter is before the Court on Defendant Novartis Pharmaceuticals Corporation’s motion to dismiss with prejudice this lawsuit filed by Plaintiff John Rapa. For the reasons set forth below, Defendant’s motion to dismiss shall be granted.

BACKGROUND

On October 30, 2008, Plaintiff John Rapa (“Plaintiff’), a Missouri resident, filed a complaint against Defendant alleging five tort claims after he developed osteonecro-sis of the jaw as a side effect of Aredia, a drug manufactured by Defendant. The case was consolidated for pretrial proceedings and transferred as a part of multidis-trict litigation to the Middle District of Tennessee (“the MDL court”) on November 24, 2008.

Unfortunately, Plaintiff passed away on December 17, 2009. A suggestion of death was filed on July 1, 2010. (Doc. No. 12-4.) Plaintiffs counsel moved in the MDL court for provisional substitution of Plaintiffs wife, Jeanine Rapa (“Ms. Rapa”). (Doc. No. 12-5.) The MDL court granted the motion for provisional substitution. (Doc. No. 12-7.) Under the MDL court’s Case Management Order (“CMO”), provisional substitutions are conditioned on “the,substituted plaintiff submitting] to the Court prior to remand of the plaintiffs claims a copy of the Order appointing him or her as the deceased plaintiffs personal representative.” (Doe. 12-3 at 5.) On September 18, 2013, Ms. Rapa, along with her three children, obtained a determination of heir-ship from the Probate Division of the Circuit Court of St. Louis County, Missouri. (Doc. No. 12-9 at 3-4.) She never applied in probate court to be appointed Plaintiffs personal representative nor did she ever submit to the MDL court a copy of an order appointing her as such.

Upon completion of the consolidated pretrial proceedings in the action, the MDL court remanded the case back to this Court pursuant to 28 U.S.C. § 1407(a) on March 25, 2014. (Doc. No. 8.) Ms. Rapa has never applied to become nor has she ever been appointed Plaintiffs personal representative. Consequently, the issue in this case is whether, under the MDL court’s Case Management Order (“CMO”) and Missouri state law, Ms. Rapa has standing to continue this case on Plaintiffs behalf.

ARGUMENTS OF THE PARTIES

Defendant argues that the Court should dismiss this action with prejudice because Ms. Rapa lacks the proper legal authority under Missouri law to prosecute this lawsuit on behalf of her husband, and because Ms. Rapa violated the express terms of the CMO issued by the MDL court. Defendant bases the motion to dismiss on the fact that Ms. Rapa was never appointed personal representative of Plaintiff, and the time to do so has long since passed under both Missouri law and the CMO. Defendant relies on the fact that it has been over four years since Plaintiff died on December 17, 2009, and Ms. Rapa still has not been appointed her husband’s personal representative. Defendant argues that not only did Ms. Rapa fail to become so appointed within the thirty days required by the CMO, but she also missed the one-year statute of limitations under Missouri law.

Furthermore, Defendant purports that Ms. Rapa misrepresented her legal status [1152]*1152to the MDL court in the motion for provisional substitution by identifying herself as the personal representative of Plaintiff despite the fact that she was never appointed to the role.1 Defendant argues that despite her representations, Ms. Rapa was not the proper party to be substituted for Plaintiff under Missouri law, as legally required by the CMO and Federal Rule of Civil Procedure 25(a). Moreover, Defendant argues that Ms. Rapa never fulfilled the condition of provisional substitution because she never submitted an order appointing her personal representative, so the provisional substitution was extinguished upon remand. For all of these reasons, Defendant argues that this case should be dismissed with prejudice for lack of standing.

Ms. Rapa argues that the Court should deny Defendant’s motion because her substitution was proeedurally proper and because Defendant’s argument to the contrary should be barred under the doctrine of laches. In support of the claim that her substitution was proper, Ms. Rapa argues that Federal Rule of Civil Procedure 25(a) allows for flexibility and controls even when state law has different procedural requirements. Ms. Rapa alleges that her filing of a suggestion of death and motion for provisional substitution are sufficient to fulfill the procedural requirements of Rule 25(a).

Ms. Rapa also argues that, under Missouri law, the Judgment Determining Heirs was sufficient to make her the personal representative of her husband and to give her standing to pursue this case on his behalf. Ms. Rapa asserts that she would have qualified to be appointed as personal representative, if she applied, and that there is no limitation under Missouri law that prevents primary beneficiaries named in heirship determinations from being recognized as personal representatives for the purposes of actions like this one.

Alternatively, Ms. Rapa argues that Defendant’s motion to dismiss should be denied based on the doctrine of laches because of Defendant’s failure to object to the motion for provisional substitution. Ms. Rapa points to the fact that Defendant knew she only had one year after Plaintiffs death to be appointed a personal representative, but Defendant did not raise this issue until now—over two years after that time expired. Ms. Rapa asserts that “procedural technicalities should not trump the substance of the claims at issue” at this point in the proceedings. (Doc. No. 16 at 8.)

In response to Ms. Rapa’s laches argument, Defendant contends that a lack of standing cannot be waived, and, even if it could, Defendant did not learn that Ms. Rapa was never appointed personal representative of Plaintiff until after the MDL court remanded the case back to this Court.

LEGAL STANDARD

Under Federal Rule of Civil Procedure 25(a), “[i]f a party dies and the claim is not extinguished, the court may order substitution of the proper party” through a motion for substitution. Fed.R.Civ.P. 25(a). “[Sjtate law governs who can be a ‘representative’ or ‘successor,’ and therefore, who can qualify as a proper party for substitution under Rule 25(a)(1).” In re Baycol Prods. Litig., 616 F.3d 778 (8th [1153]*1153Cir.2010) (emphasis in original). Similarly, the CMO dictates that if a plaintiff dies, the applicable state law will control appointment of a personal representative on the plaintiffs behalf. (Doc. No. 12-3 at 4.) Because Plaintiff was a Missouri resident, Missouri law controls who qualifies as the proper party for substitution in order to continue this action.

Under Missouri common law, tort claims do not survive the death of the victim. Manson v. Wabash R. Co.,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re Baycol Products Litigation
616 F.3d 778 (Eighth Circuit, 2010)
Carter v. Pottenger
888 S.W.2d 710 (Missouri Court of Appeals, 1994)
Manson v. Wabash Railroad Company
338 S.W.2d 54 (Supreme Court of Missouri, 1960)
Jacqueline Wilson v. Novartis Pharmaceutica
575 F. App'x 296 (Fifth Circuit, 2014)
Sauter v. Schnuck Markets, Inc.
803 S.W.2d 54 (Missouri Court of Appeals, 1990)
Johnson v. Akers
9 S.W.3d 608 (Supreme Court of Missouri, 2000)

Cite This Page — Counsel Stack

Bluebook (online)
53 F. Supp. 3d 1150, 2014 U.S. Dist. LEXIS 146587, 2014 WL 5161311, Counsel Stack Legal Research, https://law.counselstack.com/opinion/rapa-v-novartis-pharmaceuticals-corp-moed-2014.